Organon & Co. (OGN)
Organon Market Cap : 3.656B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 3.650B |
| November 16, 2026 | 3.650B |
| November 13, 2026 | 3.650B |
| November 12, 2026 | 3.650B |
| November 11, 2026 | 3.648B |
| November 10, 2026 | 3.648B |
| November 09, 2026 | 3.637B |
| November 06, 2026 | 3.643B |
| November 05, 2026 | 3.622B |
| November 04, 2026 | 3.632B |
| November 03, 2026 | 3.637B |
| November 02, 2026 | 3.629B |
| October 30, 2026 | 3.635B |
| October 29, 2026 | 3.627B |
| October 28, 2026 | 3.619B |
| October 27, 2026 | 3.611B |
| October 26, 2026 | 3.608B |
| October 23, 2026 | 3.611B |
| October 22, 2026 | 3.611B |
| October 21, 2026 | 3.611B |
| October 20, 2026 | 3.614B |
| October 19, 2026 | 3.611B |
| October 16, 2026 | 3.614B |
| October 15, 2026 | 3.614B |
| October 14, 2026 | 3.608B |
| Date | Value |
|---|---|
| October 13, 2026 | 3.616B |
| October 12, 2026 | 3.616B |
| October 09, 2026 | 3.627B |
| October 08, 2026 | 3.611B |
| October 07, 2026 | 3.622B |
| October 06, 2026 | 3.608B |
| October 05, 2026 | 3.598B |
| October 02, 2026 | 3.603B |
| October 01, 2026 | 3.601B |
| September 30, 2026 | 3.598B |
| September 29, 2026 | 3.608B |
| September 28, 2026 | 3.606B |
| September 25, 2026 | 3.606B |
| September 24, 2026 | 3.603B |
| September 23, 2026 | 3.606B |
| September 22, 2026 | 3.598B |
| September 21, 2026 | 3.592B |
| September 18, 2026 | 3.592B |
| September 17, 2026 | 3.595B |
| September 16, 2026 | 3.590B |
| September 15, 2026 | 3.587B |
| September 14, 2026 | 3.585B |
| September 11, 2026 | 3.582B |
| September 10, 2026 | 3.579B |
| September 09, 2026 | 3.590B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Viatris, Inc. | 23.24B |
| Pacira Biosciences, Inc. | 1.455B |
| ANI Pharmaceuticals, Inc. | 1.591B |
| Corcept Therapeutics, Inc. | 7.406B |
| Veru, Inc. | 39.39M |
Market Cap Related Metrics
| PE Ratio | 18.10 |
| PS Ratio | 0.6082 |
| Price to Book Value | 3.064 |
| Price to Free Cash Flow | 5.047 |
| Price | 13.92 |
| Earnings Yield | 5.52% |
| Operating PE Ratio | 3.101 |
| Normalized PE Ratio | 9.585 |